Welcome to LookChem.com Sign In|Join Free

CAS

  • or

267416-81-9

Post Buying Request

267416-81-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

267416-81-9 Usage

General Description

5-AMINO-2-(PHENOXY)BENZOTRIFLUORIDE is an organic compound that belongs to the class of benzenesulfonamides. It is a white solid at room temperature with a molecular formula of C13H10F3NO. This chemical is primarily used as a building block in the synthesis of pharmaceuticals and agrochemicals. It is also used as a reagent in organic synthesis, particularly in the preparation of heterocyclic compounds. 5-AMINO-2-(PHENOXY)BENZOTRIFLUORIDE is known for its strong electron-withdrawing properties due to the presence of the trifluoromethyl group, making it a versatile compound for various chemical reactions and applications in the field of organic chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 267416-81-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,7,4,1 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 267416-81:
(8*2)+(7*6)+(6*7)+(5*4)+(4*1)+(3*6)+(2*8)+(1*1)=159
159 % 10 = 9
So 267416-81-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H10F3NO/c14-13(15,16)11-8-9(17)6-7-12(11)18-10-4-2-1-3-5-10/h1-8H,17H2

267416-81-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H33517)  4-Phenoxy-3-(trifluoromethyl)aniline, 97%   

  • 267416-81-9

  • 1g

  • 1110.0CNY

  • Detail
  • Alfa Aesar

  • (H33517)  4-Phenoxy-3-(trifluoromethyl)aniline, 97%   

  • 267416-81-9

  • 5g

  • 4459.0CNY

  • Detail

267416-81-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-phenoxy-3-(trifluoromethyl)aniline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:267416-81-9 SDS

267416-81-9Downstream Products

267416-81-9Relevant articles and documents

Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents

Fujii, Shinya,Kikuchi, Eriko,Suzuyama, Honoka,Watanabe, Yuko,Ishigami-Yuasa, Mari,Masuno, Hiroyuki,Mori, Takayasu,Isobe, Kiyoshi,Uchida, Shinichi,Kagechika, Hiroyuki

, p. 2817 - 2822 (2021/07/12)

Hypertension is an important target for drug discovery. We have focused on the with-no-lysine kinase (WNK)-oxidative stress-responsive 1 (OSR1) and STE20/SPS1-related proline-alanine-rich protein kinase (SPAK)-NaCl cotransporter (NCC) signal cascade as a potential target, and we previously developed a screening system for inhibitors of WNK-OSR1/SPAK-NCC signaling. Herein we used this system to examine the structure-activity relationship (SAR) of salicylanilide derivatives as SPAK kinase inhibitors. Structural design and development based on our previous hit compound, aryloxybenzanilide derivative 2, and the veterinary anthelmintic closantel (3) led to the discovery of compound 10 a as a potent SPAK inhibitor with reduced toxicity. Compound 10 a decreased the phosphorylation level of NCC in mouse kidney in vivo, and appears to be a promising lead compound for a new class of antihypertensive drugs.

Substituted bicyclic derivatives useful as anticancer agents

-

, (2008/06/13)

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts and solvates thereof, wherein A, X, R1, R3and R4are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals with administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 267416-81-9